by publisher – Page 4 – Retraction Watch

Thousands demand withdrawal of review article recommending exercise therapy for chronic fatigue syndrome

The decision to abandon a process to re-evaluate a review recommending exercise therapy for chronic fatigue syndrome (ME/CFS) has reignited calls for the article to be withdrawn.

The 2019 version of the Cochrane Library review, “Exercise therapy for chronic fatigue syndrome,” has accumulated 67 citations, according to Clarivate’s Web of Science.

The review recommends exercise therapy to treat ME/CFS, a treatment approach that drew widespread criticism from the patient community and researchers, who say physical activity isn’t an adequate remedy for the condition. According to the petition, Cochrane’s former editor-in-chief admitted the review in question wasn’t “fit for purpose,” although the editor-in-chief’s statement did not use that phrase.

‘Foolish mistake’: Guest editor loses three articles published in his own special issues

An Elsevier journal has pulled three articles after the publisher determined an author had been “involved in the peer review and decision making” as managing guest editor of the special issues in which they appeared.

The author, botany researcher Vijay Kumar of Lovely Professional University in Punjab, India, told Retraction Watch his apparent involvement in assigning reviewers was “purely unintentional” and a “foolish mistake.”

Two of the articles appeared in a special issue section of the South African Journal of Botany in 2022. They were:

Pair of management papers retracted for similarities to earlier work

Two management journals from the same publisher have retracted a pair of articles for taking “models, samples, and results” from each other and earlier work.

A tip from an anonymous account sent in November to Retraction Watch, sleuth Elisabeth Bik, and others called out duplications in the papers. Bik then posted the two articles on PubPeer in November 2024, noting several identical sets of tables between the papers, despite the works investigating survey data on different topics from different populations — intention to leave among employees from the hospitality sector, and resistance to change among managers at private organizations.

Sage slaps more than 100 papers from one journal with expressions of concern

The Sage journal American Surgeon has issued a mass expression of concern for 116 articles.

The expression of concern states the journal “was made aware” of “concerning author activity” on the articles.

Sage is no stranger to mass editorial actions. In 2023, the publisher pulled large tranches of papers at least three times, and last year it retracted over 450 papers from a journal the company had acquired from IOS Press. The publisher was one of the first to begin retracting papers in bulk, primarily to combat manipulated peer review.

Elsevier denies AI use in response to evolution journal board resignations

The publisher of the Journal of Human Evolution says it does not use artificial intelligence in its production process, contrary to a statement issued last month by the journal’s editorial board when all but one member of the group resigned.

The statement, shared on X on December 26, noted the journal’s “joint Editors-in-Chief, all Emeritus Editors retired or active in the field, and all but one Associate Editor” were resigning because Elsevier, the journal’s publisher, “has steadily eroded the infrastructure essential to the success of the journal while simultaneously undermining the core principles and practices that have successfully guided the journal for the past 38 years.” Among the examples cited:

Evolution journal editors resign en masse to protest Elsevier changes

All but one member of the editorial board of the Journal of Human Evolution (JHE), an Elsevier title, have resigned, saying the “sustained actions of Elsevier are fundamentally incompatible with the ethos of the journal and preclude maintaining the quality and integrity fundamental to JHE’s success.”

“Elsevier has steadily eroded the infrastructure essential to the success of the journal while simultaneously undermining the core principles and practices that have successfully guided the journal for the past 38 years,” the journal’s “joint Editors-in-Chief, all Emeritus Editors retired or active in the field, and all but one Associate Editor” said in their resignation statement posted to X/Twitter yesterday.

Among other moves, according to the statement, Elsevier “eliminated support for a copy editor and special issues editor,” which they interpreted as saying “editors should not be paying attention to language, grammar, readability, consistency, or accuracy of proper nomenclature or formatting.” The editors say the publisher “frequently introduces errors during production that were not present in the accepted manuscript:”

Finland Publication Forum will downgrade hundreds of Frontiers and MDPI journals

A committee of scholars in Finland has decided to downgrade 271 journals from Frontiers and MDPI in their quality rating system, in a move that may discourage researchers from submitting manuscripts to the outlets.

Both publishers criticized the move, first reported in Times Higher Education, as lacking transparency and seeming to target fully open-access publishers.

Finland’s Publication Forum (JUFO) “is a rating and classification system to support the quality assessment of research output,” which factors into government funding for universities, according to its website. “The objective is to encourage Finnish scholars and researchers to publish their research outcomes in high-level domestic and foreign forums.”

Journal won’t retract paper that involved human organ transplants in China

The Journal of Heart and Lung Transplantation (JHLT) has decided against retracting a November 2024 paper that violated the ethics policy of the publication.

After publishing the paper, which describes a new mechanical circulatory support device used to treat heart failure that was developed in China, staff at the journal realised two of the patients in the study had received organ transplants in that country.

Dozens of research articles have been retracted or flagged for appearing to have used organs procured from executed prisoners in China, and many journals around the world have introduced policies to avoid such research. JHLT’s ethics statement, published in 2022, bans data on human organ transplants from journals or scientific sessions when they originate from countries, particularly China, where organ procurement from prisoners has been observed.

19 months and counting: Former Hindawi journal still hasn’t marked paper

A journal formerly published by Hindawi has yet to publish any sort of notice on a paper sleuths reported for containing duplicated images 1.5 years ago.

According to Kevin Patrick, the sleuth who contacted the publisher in mid-2023, the episode “might be a useful case study” of the issues facing Wiley, which acquired Hindawi in 2021 and stopped using the brand name earlier this year after retracting thousands of papers and closing journals overrun by paper mills.

The article, “Resveratrol Derivative, Trans-3, 5, 4 ′-Trimethoxystilbene Sensitizes Osteosarcoma Cells to Apoptosis via ROS-Induced Caspases Activation,” appeared in Oxidative Medicine and Cellular Longevity in 2021. Clarivate removed the journal from its Web of Science index in March 2023 for failing to meet quality criteria.

In April 2023, Elisabeth Bik left a comment on PubPeer, noting “several figures in this paper look identical to figures in a 2019 paper by some of the same authors,” which had been retracted. “I could not find wording about e.g. a republication of part of that study, and the 2019 paper is not included in the references,” she wrote.

Wiley medical journal retracts dozens of papers for manipulated peer review, with more to come

International Wound Journal, a Wiley title, has retracted 27 papers since June with notices mentioning “manipulated” or “compromised” peer review.

“A comprehensive investigation examining manipulated peer review in this journal is in progress,” a Wiley spokesperson told Retraction Watch. The publisher anticipates retracting more articles as the investigation continues.

The first retraction of the batch, of the November 2023 article “Analysis of the Association Between Serum Levels of 25(OH)D, Retinol Binding Protein, and Cyclooxygenase-2 and the Disease Severity in Patients with Diabetic Foot Ulcers,” appeared June 14. The notice stated Wiley and the journal’s editor in chief “concluded that the peer review process of this article was manipulated” following an investigation by the publisher.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: